Reuse of single-use devices
This article was originally published in The Gray Sheet
Executive Summary
Senate Health Committee Chairman James Jeffords (R-Vt.) and panel member Bill Frist (R-Tenn.) request in a July 2 letter to FDA Commissioner Jane Henney that the agency provide by July 12 an explanation as to the "current activities...being taken by FDA to ensure that all reprocessed single-use devices are safe and effective for their intended use." The senators also ask FDA to explain its "future plans...to address this issue, including a detailed timeline for full implementation." The agency also is requested to specify whether it believes "new legislative authority is necessary for FDA to require" registration of and premarket submissions from device reprocessors. In addition, FDA is asked to supply the "total number" and a "complete list" of reprocessed, single-use devices
You may also be interested in...
GAO Inquiry Into Device Reprocessing, FDA Oversight To Be Sought By Senate
The Senate Health, Education, Labor and Pensions Committee will ask the General Accounting Office to undertake a comprehensive evaluation of the practice of reprocessing devices, according to committee staffers.
GAO Inquiry Into Device Reprocessing, FDA Oversight To Be Sought By Senate
The Senate Health, Education, Labor and Pensions Committee will ask the General Accounting Office to undertake a comprehensive evaluation of the practice of reprocessing devices, according to committee staffers.
Reuse of single-use devices
Senate Health Committee intends to hold a hearing on the contentious issue to gather information, possibly before the August congressional recess, according to committee staffers. As of late July 16, the committee had yet to receive FDA's response to its request for details regarding the agency's plans for regulating reprocessed single-use devices (1"The Gray Sheet" July 12, In Brief)